10,000
Participants
Start Date
April 24, 2024
Primary Completion Date
November 30, 2026
Study Completion Date
January 30, 2027
Pulsed Field Ablation
Ablation using the Boston Scientific Farapulse Pulsed Field Ablation System for the treatment of atrial fibrillation (AF)
Allegheny General Hospital, Pittsburgh
WellSpan Health, York
HCA Research Institute - Chippenham Hospital, Richmond
HCA Research Institute Mission Hospital, Asheville
HCA - Trident Medical Center, North Charleston
Ascension St. Vincent's, Jacksonville
HCA Florida Mercy Hospital, Miami
The Arrythmia Center of South Florida, Delray Beach
Sarasota Memorial Hospital, Sarasota
Arrhythmia Institute at Grandview, Birmingham
Ascension St. Thomas Nashville, Nashville
Norton Heart & Vascular Institute, Louisville
OhioHealth Research Institute, Columbus
The Christ Hospital - Heart & Vascular, Cincinnati
The Christ Hospital, Cincinnati
Ascension St Vincent -Indianapolis Ascension Healt, Indianapolis
MercyOne Iowa Heart Center, West Des Moines
Endeavor Health (Northshore), Glenview
Arrhythmia Research Group, Jonesboro
Ascension Texas Cardiovascular, Austin
Texas Cardiac Arrhythmia Research Foundation (St. Davids), Austin
St. Mark's Hospital, Salt Lake City
Community Memorial Health Systems, Ventura
Brigham and Women's Hospital, Boston
Cardiovascular Associates of Delaware Valley, Haddon Heights
Collaborators (1)
Boston Scientific Corporation
INDUSTRY
Heart Rhythm Clinical and Research Solutions, LLC
OTHER